Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

2,233 total articles

Unusual Machines: Upgrade to Buy as Execution Meets Opportunity

Unusual Machines: Upgrade to Buy as Execution Meets Opportunity

Unusual Machines (UMAC) is transitioning from growth story to execution. After doubling 2025 revenue to $11.2M and signalling positive operating cash flow by year-end 2026, the company has the balance sheet and exposure to domestic defense demand to scale. We upgrade to Buy and lay out a disciplined entry at $20.00, stop at $16.50 and a $35.00 targ…

Henry Schein Is a Buy Now, But Don't Be Complacent - Trade Plan Inside

Henry Schein Is a Buy Now, But Don't Be Complacent - Trade Plan Inside

Henry Schein ($HSIC) looks attractively priced relative to cash flow and peers in medical distribution. The company's $200M efficiency plan, steady free cash flow ($573M), and expanding partnerships provide upside. However, recent margin softness in dental operations, litigation headlines, and mixed technicals argue for a controlled entry, defined …

Netskope Setup: Buy Into FCF Turnaround and Diminishing Lockup Pressure

Netskope Setup: Buy Into FCF Turnaround and Diminishing Lockup Pressure

Netskope (NTSK) is trading near its 52-week low despite 33% sales growth and a reported 118% net retention rate. With a market cap near $3.69B, improving cash dynamics that management highlights as moving to free-cash-flow positive, and technicals showing a decent base, this is a tactical mid-term long: enter at $9.40, stop at $8.50, target $15.00 …

Fulgent Genetics: Oversold, Underpriced, and Misunderstood

Fulgent Genetics: Oversold, Underpriced, and Misunderstood

Fulgent Genetics (FLGT) trades near cycle lows at ~$14.19 despite a technology-led testing platform, a clean balance sheet, and valuation multiples that look cheap relative to recovery scenarios. The market has punished the stock for legal inquiries and margin volatility; that reaction appears overdone. This trade idea lays out a mid-term long with…

Why Amazon Is a Buy Now: AWS, Ads and AI Will Force a Re-rating

Why Amazon Is a Buy Now: AWS, Ads and AI Will Force a Re-rating

Amazon looks misunderstood by the market. Between structurally higher-margin AWS, accelerating advertising, and expanding AI monetization vectors, the stock offers an asymmetric risk-reward for a mid-term swing. I outline an actionable trade with entry, stop and target, catalysts to watch and what would change my view.

Whirlpool: A Swing Trade as Headwinds Flip to Tailwinds

Whirlpool: A Swing Trade as Headwinds Flip to Tailwinds

Whirlpool (WHR) has been hammered by tariff pain, a dilutive capital raise and a cooling housing cycle. Those headwinds look to be peaking: the company sits at single-digit P/E-like valuation, yields well above 6%, and technicals are deeply oversold. This trade idea proposes a mid-term swing long with a disciplined stop and clear targets while ackn…

ONEOK: Buy the Yield, Hold the Growth - Tactical Swing into $95

ONEOK: Buy the Yield, Hold the Growth - Tactical Swing into $95

Oneok (OKE) offers a compelling mix of steady fee-based revenue, a near-5% yield, and valuation that still looks reasonable after recent gains. With multiple expansion projects coming online through 2028 and payout-backed free cash flow, a tactical long into $95 with a $79 stop captures both income and upside while keeping risk defined.

Buy Nebius: Nvidia’s $2B Bet Makes Europe’s AI Cloud Investible

Buy Nebius: Nvidia’s $2B Bet Makes Europe’s AI Cloud Investible

Nvidia's $2 billion strategic investment and a string of commercial wins turn Nebius from a regional builder into a global AI infrastructure play. Growth and capacity visibility justify a long trade into $112 with a measured stop and a $145 target over a 180-trading-day horizon, while risks around financing, valuation, and concentration warrant tig…